CONGRESS FOR VOTERS

Bill · H.R. 4299· House(119-HR-4299)

Protecting Patient Access to Cancer and Complex Therapies Act

Rep. Murphy

Age: 63 years

North Carolina

Introduced: 7/7/2025
Last activity: 7/7/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by: Gregory Murphy
Cosponsors: - 38 - 17

Health

Introduced
In Committee

What this bill would do

This bill is titled the Protecting Patient Access to Cancer and Complex Therapies Act.
- It amends title XVIII of the Social Security Act.
- The legislation requires manufacturers to provide a rebate for selected drugs and biological products that are subject to maximum fair price negotiation.
- It outlines the specific calculations for these manufacturer rebates and beneficiary coinsurance amounts.
- The bill directs rebate deposits into the Federal Supplementary Medical Insurance Trust Fund.
- It also establishes penalties for failing to comply with the rebate requirements.

Yes· 3 of 13

Would people over 65 be better off under this?+7
Directly reduces out-of-pocket drug costs for Medicare beneficiaries, who are predominantly seniors.
Would retired people be better off under this?+7
Lowers medical costs for retirees on Medicare Part B.
Would households on low incomes be better off under this?+6
Reduces the financial burden of expensive cancer and complex therapies.

The opposite

Would business owners be better off under this?-4
Increases financial burden on drug manufacturers through mandatory rebates.